Create
Log in
Enquire now
ARMO BioSciences
ARMO BioSciences was a Redwood City, California-based biotechnology company.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Organization
Company
Acquisition Transaction
Acquisition of ARMO BioSciences by Eli Lilly and Company
Acquirer
Eli Lilly
B2X
B2B2C
Business Model
Commerce
CEO
Peter Van Vlasselaer
CIK Number
1,693,664
0
Legal Name
ArmO BioSciences, Inc.
Company Operating Status
Active
Crunchbase URL
crunchbase.com/organiz...sciences
Date Incorporated
2010
Email Address
info@armobio.com
Founder
Peter Van Vlasselaer
Full Address
575 Chesapeake Drive Redwood City, CA 94063
Industry
Internal medicine
Healthcare
Medical imaging
Biotechnology
Biology
Technology
Medicine
Radiology
Life science
Pharmaceutical industry
•••
Investors
OrbiMed
Decheng Capital
HBM Healthcare Investments AG
QiMing Venture Partners
NanoDimension
RTW Investments LLC
Quan Capital
Sequoia Capital
Kleiner Perkins Caufield & Byers
Google Ventures
•••
IRS Number
273,454,138
0
Latest Funding Round Date
August 29, 2017
Latest Funding Type
Series C
Legal classification
Incorporation (business)
Corporation
LinkedIn URL
@company/armo-biosciences
Location
Palo Alto, California
Redwood City, California
Number of Employees (Ranges)
11 – 50
Parent Organization
Eli Lilly
Patents Assigned (Count)
12
Phone Number
+16507795075
Pitchbook URL
pitchbook.com/profiles.../60474-61
Place of Incorporation
Delaware
0
SIC Code
2,834
0
Total Funding Amount (USD)
167,000,000
Official Website
armobio.com
Find more companies like ARMO BioSciences
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE